Analyst picks & changes

Transkaryotic Therapies Inc. (TKTX), Cambridge, Mass.

Business: Gene/Cell therapy

Montgomery Securities analyst David Crossen

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE